Studies involving patients with pathological cardiac hypertrophy and heart failure have shown elevated levels of angiotensin II (Ang II), endothelin-1 (ET-1), insulin-like growth factor 1 (IGF-1), and catecholamines compared to healthy individuals. The gene discussed is IGF1; the disease is heart failure.